Canberra Keeps Puberty Blockers on the Table for Children as Other Countries Pull Back

Canberra Keeps Puberty Blockers on the Table for Children as Other Countries Pull Back

THEMES:

Australia's national health research body has recommended that puberty blockers stay available to children with gender dysphoria, even as the United Kingdom, New Zealand and Queensland move to restrict them. The advice was commissioned by Health Minister Mark Butler, who now says what happens next is up to the states.

Canberra Is Walking Against the Tide

On Monday 16 November, the National Health and Medical Research Council (NHMRC) released draft advice backing puberty blockers as a clinical option for young people who have gender incongruence or gender dysphoria, have begun puberty and have been assessed as suitable, the ABC reported. Treatment would follow shared decision-making between the young person, their carers, and clinicians.

Overseas, the direction of travel is very different. NHS England's final policy, published in March 2024, ended routine provision of puberty blockers to under-18s with gender dysphoria, according to the UK government's consultation record. In December 2024, the British government made its ban on private prescriptions indefinite after its independent Commission on Human Medicines found an “unacceptable safety risk” in continuing to prescribe them to children.

In November 2025, New Zealand announced a halt on new prescriptions, following a 2024 Health Ministry report that found a lack of high-quality evidence on the benefits or risks. Its High Court set those regulations aside last month on consultation and discrimination grounds, though the government says it will bring in new safeguards. Queensland has paused new patients in its public system since January 2025, and last December extended the pause until 2031, when results from the UK's PATHWAYS trial are due. Health Minister Tim Nicholls has pointed to similar restrictions in France, Finland, Norway, Denmark and Sweden. On Monday, the 16th of November, Queensland and the Northern Territory both said their positions were unchanged.

A Recommendation Resting on Low-Certainty Evidence

The NHMRC's own review included just 15 non-randomised studies, most following participants for between six months and two years, and rated the overall certainty of the evidence as low, the ABC reported. The committee pointed to possible benefits for psychosocial functioning and said serious adverse events appear rare. But it found no eligible evidence on fertility, fractures or other measures of bone health, and other long-term questions.

Queensland's 530-page independent review, led by psychiatrist Ruth Vine, found limited evidence of health or psychosocial benefits in any time frame. Britain and New Zealand responded to that kind of uncertainty with caution. Australia's national body has responded with a recommendation.

Break the lies of the Sexual Revolution – share this article!

(Article continues below this message)

The LGBT lobby presents its agenda as 'love' and 'freedom,' but the consequences are confusion, brokenness, and lifelong medical damage. The media and politics are rife with rainbow campaigns, while sober facts and Christian objections are dismissed. Therefore, share this article with family and friends – the more people see the truth, the harder it becomes to force the next generation into the valueless straitjacket of the Sexual Revolution!

Also read: WPATH Admits Its Gender Guidelines Are Not Based on Medical Facts

The Government That Ordered the Review Says It Is Not Its Call

Mr Butler announced the NHMRC review on the 31st of January 2025, days after Queensland paused new treatment. By November 2025, he was telling The Australian that any pause on puberty blockers was ultimately a matter for state governments. After Monday's release, he took the same line, saying he was confident states would weigh the advice closely but that any change was up to them.

As Mr Butler noted in January 2025, scripts for puberty blockers are issued by state governments and their clinicians. Canberra supplies a national endorsement, while responsibility for prescribing sits with the states. The advice itself is not binding, and the full national guidelines, which will also cover hormones, are not due until 2028.

NHMRC acting chief executive Prue Torrance has described puberty suppressants as one possible part of care, to be decided through shared decision-making involving the young person, their parents or carers and clinicians. But the government that ordered the review is not the one that will answer for what happens in the clinic.

Too Young for TikTok, But Old Enough for Puberty Blockers?

Women's rights activist Sall Grover, the Giggle for Girls CEO, told News24.com.au she finds the recommendation “very, very sinister”. She argues that if Australians under 16 are barred from social media, they should not be able to access life-changing pharmaceuticals, and that anyone proposing to give children such drugs should demand overwhelming proof they are necessary. Puberty, she said, is a physical, mental and emotional pathway from childhood to adulthood.

Her point about licensing has a basis in Health Department briefing material released under freedom of information, which states that the Therapeutic Goods Administration has approved these medicines for conditions such as precocious puberty and certain cancers, but not specifically for gender-affirming care.

Ms Grover also asked why a government that, in her account, told women's rights campaigners that fixing the Sex Discrimination Act was a culture war issue it would stay out of, is so determined when it comes to blocking children's puberty. She rejected the idea that only doctors may speak on the issue, arguing that you do not need to be one to know children should not be unnecessarily prescribed life-altering hormones.

Her question is the one Australian parents are entitled to put to Canberra: if the evidence is this uncertain, why does the national advice keep the option open?

Last updated: 18 November 2026 04:53

Donate